# OnCo record paper-lutetium-177-vipivotide-tetrax-prostate-journal-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-lutetium-177-vipivotide-tetrax-prostate-journal-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-lutetium-177-vipivotide-tetrax-prostate-journal-2023" ;
  schema:name "Lutetium-177 vipivotide tetraxetan for treating PSMA-positive hormone-relapsed metastatic prostate cancer after 2 or more treatments"@en ;
  schema:description "Review on Lutetium-177 vipivotide tetraxetan in Prostate cancer, in Journal not given (2023), one of the most cited Europe PMC records with Lutetium-177 vipivotide tetraxetan in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-lutetium-177-vipivotide-tetrax-prostate-journal-2023/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/40209019/>, <https://europepmc.org/article/MED/40209019> ;
  onco:tag "europepmc-ingest" ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Authors not listed" .